Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Shun-Ichi Kimura, MD PhD, Yoshinobu Kanda, MD PhD, Masaki Iino, MD PhD, Takahiro Fukuda, MD PhD, Emiko Sakaida, MD PhD, Tatsuo Oyake, Hiroki Yamaguchi, MD PhD, Shin-ichiro Fujiwara, MD PhD, Junji Suzumiya, MD PhD, Akinao Okamoto, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Takamatsu, MD PhD, Yoshio Saburi, MD PhD, Jun Yamanouchi, MD PhD, Itaru Matsumura, MD, Souichi Shiratori, Moritaka Gotoh, MD PhD, Shingen Nakamura, MD PhD, Kazuo Tamura, MD PhD

Blood (2018) 132 (Supplement 1): 816.

https://doi.org/10.1182/blood-2018-99-111154

Published: 2018

Journal Articles

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

Hayato Tamai, MD PhD, Hiroki Yamaguchi, MD PhD, Koichi Miyake, MD PhD, Miyuki Takatori, Tomoaki Kitano, Syunsuke Yui, MD, Keiko Fukunaga, MD, Kazutaka Nakayama, MD PhD, Koiti Inokuchi, PhD MD

Blood (2016) 128 (22): 1590.

https://doi.org/10.1182/blood.V128.22.1590.1590

Published: 2016

Journal Articles

The Clinical Features and Prognostic Impact of PRDM16 gene Expression in Adult Acute Myeloid Leukemia

Genki Yamato, MD, Hiroki Yamaguchi, MD PhD, Hiroshi Handa, MD PhD, Norio Shiba, MD PhD, Satoshi Wakita, Koiti Inokuchi, MD PhD Prof, Yusuke Hara, MD, Kentaro Ohki, MD PhD, Jun Okubo, MD PhD, Manabu Sotomatsu, MD, Hirokazu Arakawa, MD PhD, Yasuhide Hayashi, MD PhD

Blood (2016) 128 (22): 5228.

https://doi.org/10.1182/blood.V128.22.5228.5228

Published: 2016

Journal Articles

Analysis of Genetic Mutation of the Elderly Patients with Acute Myeloid Leukemia

Blood (2016) 128 (22): 5172.

https://doi.org/10.1182/blood.V128.22.5172.5172

Published: 2016

Journal Articles

The D816V C-Kit Mutation Confers Higher Proliferation Activity By JAK-STAT and Src Family Kinase Pathways Compared to N822K C-Kit Mutation in Core-Binding Factor Acute Myeloid Leukemia

Ikuko Omori, MD, Hiroki Yamaguchi, MD PhD, Tomoaki Kitano, Noriko Miyake, PhD, Koichi Miyake, MD PhD, Koiti Inokuchi, PhD MD

Blood (2014) 124 (21): 2224.

https://doi.org/10.1182/blood.V124.21.2224.2224

Published: 2014

Journal Articles

The Clinical and Genetic Features of Dyskeratosis Congenita, Cryptic Dyskeratosis Congenita, and Hoyeraal-Hreidarsson Syndrome in Japan

Hiroki Yamaguchi, MD PhD, Hirotoshi Sakaguchi, MD, Kenichi Yoshida, MD PhD, Miharu Yabe, MD PhD, Hiromasa Yabe, MD PhD, Yusuke Okuno, MD PhD, Hideki Muramatsu, MD PhD, Shunsuke Yui, Koiti Inokuchi, PhD MD, Etsuro Ito, MD PhD, Seishi Ogawa, MD PhD, Seiji Kojima, MD PhD

Blood (2014) 124 (21): 1608.

https://doi.org/10.1182/blood.V124.21.1608.1608

Published: 2014

Journal Articles

The Prognostic Impact Of Complex Gene Mutation In The Intermediate Risk Karyotype Acute Myeloid Leukemia

Satoshi Wakita, MD, PhD, Hiroki Yamaguchi, MD, PhD, Takeshi Ryotokuji, MD, Tuneaki Hirakawa, MD, PhD, Ikuko Omori, Tomoaki Kitano, Kunihito Arai, Yoshio Mitamura, Fumiko Kosaka, Kazuo Dan, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 1418.

https://doi.org/10.1182/blood.V122.21.1418.1418

Published: 2013

Journal Articles

Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

Hayato Tamai, MD, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2016.

https://doi.org/10.1182/blood.V122.21.2016.2016

Published: 2013

Journal Articles

The Clinical Features and Prognostic Impact of DNMT3A Gene Mutation in Japanese Patients with De Novo AML

Takeshi Ryotokuji, MD, Hiroki Yamaguchi, MD, PhD, Ikuko Omori, Tuneaki Hirakawa, MD, PhD, Satoshi Wakita, MD, Tomoaki Kitano, Yoshio Mitamura, Fumiko Kosaka, Takashi Shimada, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2011) 118 (21): 2537.

https://doi.org/10.1182/blood.V118.21.2537.2537

Published: 2011

Journal Articles

Gene Mutations in Paired Initial Presentation and Relapse Samples From Acute Myeloid Leukemia Patients,

Satoshi Wakita, MD, Hiroki Yamaguchi, MD, PhD, Yoshio Mitamura, Fumiko Kosaka, Takashi Shimada, MD, PhD, Koiti Inokuchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2011) 118 (21): 3592.

https://doi.org/10.1182/blood.V118.21.3592.3592

Published: 2011

Journal Articles

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Hiroki Yamaguchi, MD, PhD, Masahiro Okabe, MD, Kazuo Dan, MD, PhD, Koiti Inokuchi, PhD, MD, Takashi Shimada, MD, PHD

Blood (2010) 116 (21): 2477.

https://doi.org/10.1182/blood.V116.21.2477.2477

Published: 2010

Journal Articles

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Hayato Tamai, MD, Koichi Miyake, MD, PhD, Miyuki Takatori, Noriko Miyake, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD, Takashi Shimada, MD, PHD, Koiti Inokuchi, PhD, MD

Blood (2010) 116 (21): 61.

https://doi.org/10.1182/blood.V116.21.61.61

Published: 2010

Journal Articles

Novel Mutations of the JAK2 Gene and Erythropoietin Receptor Gene in Japanese Chronic Myeloproliferative Diseases.

Mitsuharu Inami, MD, PhD, Hiroki Yamaguchi, MD, PhD, Setsuo Hasegawa, MD, PhD, Seiji Gomi, MD, PhD, Ayako Watanabe, MD, PhD, Fumiko Kosaka, Yoshio Mitamura, Ai Kobayashi, Sayaka Kimura, Kazuo Dan, MD, Koiti Inokuchi, MD, PhD

Blood (2007) 110 (11): 2535.

https://doi.org/10.1182/blood.V110.11.2535.2535

Published: 2007

Journal Articles

MLL-AF4 and FLT3 Activation Synergize To Induce Multi Step Leukemogenesis.

Hiroki Yamaguchi, MD, PhD, Koiti Inokuchi, MD.PhD., Hideki Hanawa, MD.PhD., Kazuhiro Sawaguchi, Yoshio Mitamura, Naoya Uchida, MD., Mituharu Inami, MD., Takashi Shimada, MD.PhD., Kazuo Dan, MD.PhD.

Blood (2006) 108 (11): 4321.

https://doi.org/10.1182/blood.V108.11.4321.4321

Published: 2006

Journal Articles

Identification and Functional Characterization of Telomerase RNA Variant Alleles in Japanese Patients with Aplastic Anemia or Myelodysplastic Syndrome.

Junko Takeuchi, MD, Ly Hinh, PhD, Beauchamp Adam, PhD, Koiti Inokuchi, MD, PhD, Fumiko Kosaka, Kazuhiro Sawaguchi, Yoshio Mitamura, Ayako Watanabe, MD, PhD, Seiji Gomi, MD, PhD, Hiroki Yamaguchi, MD, PhD, Kazuo Dan, MD, PhD

Blood (2006) 108 (11): 977.

https://doi.org/10.1182/blood.V108.11.977.977

Published: 2006

Journal Articles

Hematopoietic Differentiation of ES Cells from P230 Bcr/Abl Transgenic Mouse.

Sakae Tanosaki, MD, PhD, Koiti Inokuchi, MD, PhD., Kazuhiro Sawaguchi, Jyunko Takeuchi, MD., Masato Tamai, MD., Naoya Uchida, MD., Ayako Watanabe, MD., Mituharu Inami, MD., Hiroki Yamaguchi, MD, PhD., Kazuo Dan, MD, PhD.

Blood (2005) 106 (11): 4331.

https://doi.org/10.1182/blood.V106.11.4331.4331

Published: 2005

Journal Articles

The DCC Heterozygote Reduces the Latency Period and Changes the Disease Phenotype of Myeloproliferative Disease in p230BCR/ABL-Expressing Mice.

Koiti Inokuchi, MD., PhD., Mituharu Inami, MD., Yazhu Wang, MD., Ayako Watanabe, MD., Hiroki Yamaguchi, MD., PhD., Sakae Tanosaki, MD., PhD., Takashi Shimada, MD., PhD, Kazuo Dan, MD., PhD

Blood (2004) 104 (11): 2968.

https://doi.org/10.1182/blood.V104.11.2968.2968

Published: 2004

NARROW

Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group

Amlexanox As a Possible Breakthrough Drug for MLL/AF4 -Positive Acute Lymphoblastic Leukemia

The Clinical Features and Prognostic Impact of PRDM16 gene Expression in Adult Acute Myeloid Leukemia

Analysis of Genetic Mutation of the Elderly Patients with Acute Myeloid Leukemia

The D816V C-Kit Mutation Confers Higher Proliferation Activity By JAK-STAT and Src Family Kinase Pathways Compared to N822K C-Kit Mutation in Core-Binding Factor Acute Myeloid Leukemia

The Clinical and Genetic Features of Dyskeratosis Congenita, Cryptic Dyskeratosis Congenita, and Hoyeraal-Hreidarsson Syndrome in Japan

The Prognostic Impact Of Complex Gene Mutation In The Intermediate Risk Karyotype Acute Myeloid Leukemia

Inhibition Of S100A6 Induces Graft Versus Leukemia Effects In MLL/AF4-Positive ALL In Human PBMC-SCID Mice

The Clinical Features and Prognostic Impact of DNMT3A Gene Mutation in Japanese Patients with De Novo AML

Gene Mutations in Paired Initial Presentation and Relapse Samples From Acute Myeloid Leukemia Patients,

MLL/AF4 Positive Acute Lymphoblastic Leukemia Has Resistance to Tumor Necrosis Factor-Alpha Caused by up-Regration of S100A6

The Activated K-RAS Protein Accelerates Human Derived-MLL/AF4 Induced Leukemo-Lymphomogenicity In Transgenic Mice Model

Novel Mutations of the JAK2 Gene and Erythropoietin Receptor Gene in Japanese Chronic Myeloproliferative Diseases.

MLL-AF4 and FLT3 Activation Synergize To Induce Multi Step Leukemogenesis.

Identification and Functional Characterization of Telomerase RNA Variant Alleles in Japanese Patients with Aplastic Anemia or Myelodysplastic Syndrome.

Hematopoietic Differentiation of ES Cells from P230 Bcr/Abl Transgenic Mouse.

The DCC Heterozygote Reduces the Latency Period and Changes the Disease Phenotype of Myeloproliferative Disease in p230BCR/ABL-Expressing Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only